Gorman-Rupp Co
NYSE:GRC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Gorman-Rupp Co
NYSE:GRC
|
US |
|
Adial Pharmaceuticals Inc
NASDAQ:ADIL
|
US |
|
T
|
Talanx AG
XHAM:TLX
|
DE |
|
W
|
Willis Towers Watson PLC
XBER:WTY
|
UK |
|
M
|
Melco Resorts & Entertainment Ltd
SWB:MAS
|
HK |
Wall St Price Targets
GRC Price Targets Summary
Gorman-Rupp Co
According to Wall Street analysts, the average 1-year price target for GRC is 76.5 USD with a low forecast of 74.74 USD and a high forecast of 79.8 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GRC's stock price target?
Price Target
76.5
USD
According to Wall Street analysts, the average 1-year price target for GRC is 76.5 USD with a low forecast of 74.74 USD and a high forecast of 79.8 USD.
What is the Revenue forecast for Gorman-Rupp Co?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 3 years is 5%.
What is the Gross Profit forecast for Gorman-Rupp Co?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 2 years is 8%.
What is the Operating Income forecast for Gorman-Rupp Co?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next 3 years is 15%.
What is the Pre-Tax Income forecast for Gorman-Rupp Co?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 4%. The projected CAGR for the next 2 years is 17%.
What is the Net Income forecast for Gorman-Rupp Co?
Projected CAGR
22%
Over the last 13 years, the compound annual growth rate for Net Income has been 5%. The projected CAGR for the next 3 years is 22%.